January 29, 2024
Mitsubishi Tanabe Pharma said on January 26 that it will contribute an additional 100 million yen to the Global Health Innovative Technology Fund (GHIT Fund) for its third phase of operations running for FY2023-FY2027. The Mitsubishi Chemical Group company has...read more